M40 Testosterone Replacement Therapy in Hypogonadal Men

Program: Meet-the-Professor Sessions
Clinical Session
Sunday, April 3, 2016: 10:00 AM-10:45 AM
Room 156 (BCEC)
Sunday, April 3, 2016: 2:15 PM-3:00 PM
Room 156 (BCEC)
Speaker:
Alvin M. Matsumoto, MD, VA Puget Sound Health Care System, Seattle, WA

Disclosures:
AMM: Ad Hoc Consultant, Endo Pharmaceuticals, Advisory Group Member, Clarus, Advisory Group Member, Abbott Laboratories, Principal Investigator, GlaxoSmithKline, Principal Investigator, Abbott Laboratories, Ad Hoc Consultant, Lilly USA, LLC.

 

The Endocrine Society would like to thank the following organizations for their support: AbbVie Inc.; Bayer HealthCare Pharmaceuticals Inc.; Boehringer Ingelheim Pharmaceuticals, Inc.; Chiasma, Inc.; Corcept Therapeutics Incorporated; Eisai, Inc.; Ethicon Endo-Surgery, Inc.; Genzyme, a Sanofi company, Ipsen Biopharmaceuticals, Inc.; Leona M. and Harry B. Helmsley Charitable Trust; Lilly USA, LLC; Medtronic Diabetes; Merck & Co., Inc.; Novartis Pharmaceuticals Corporation; Novo Nordisk Inc.; Pfizer, Inc.; Shire